Biocan Novel DHPPi/L4R

국가: 크로아티아

언어: 크로아티아어

출처: Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
12-10-2016

유효 성분:

liofilizat (atenuirani):virus štenećaka, soj CDV Bio 11/A; adenovirus pasa tip 2, soj CAV-2 Bio 13; parvovirus pasa tip 2b, soj CPV-2b Bio 12/B; virus parainfluenze pasa tip 2, soj CPiV-2 Bio 15 otapalo (inaktivirane): Leptospira interrogans, serogrupa Icterohaemorrhagiae, serovar Icterohaemorrhagiae, soj MSLB 1089; Leptospira interrogans, serogrupa Canicola, serovar Canicola, soj MSLB 1090; Leptospira kirschneri, serogrupa Grippotyphosa, serovar Grippotyphosa, soj MSLB 1091; Lept

제공처:

Bioveta, a.s., Komenského 212/12, 683 23 Ivanovice na Hané, Republika Češka

INN (International Name):

liofilizat (atenuirani):štenećaka virus, strain CDV was 11/A, adenovirus dogs type 2, strain CAV-2 was 13; canine parvovirus type 2B, strain CPV-2b was 12/B; the dogs parainfluenze virus type 2, strain CPiV-2 was 15 solvent (inaktivirane): Leptospira interrogans, serogrupa Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089; Leptospira interrogans, serogrupa Canicola, serovar Canicola, strain MSLB 1090; Leptospira kirschneri, serogrupa Grippotyphosa, serovar Grippotyphosa, strain MSLB 1091; L

약제 형태:

liofilizat i otapalo za suspenziju za injekciju

처방전 유형:

DA

Manufactured by:

Bioveta, a.s., Komenského 212/12, 683 23 Ivanovice na Hané, Republika Češka

치료 그룹:

pasa

치료 영역:

imunološki VMP

승인 상태:

Vrijedi

승인 날짜:

2014-06-18